⚔️ Activating the Macrophages: The Immunological Mechanism of Action for CD47 Blockade
Description: A detailed look at the clinical mechanism by which blocking the CD47-SIRPα axis leads to the activation and engagement of innate immune cells to destroy tumors.
The therapeutic action of CD47 Targeting Therapeutics is centered on re-educating the innate immune system, specifically the macrophages, to recognize and destroy cancer cells. Macrophages are professional phagocytes—cells designed to ingest and dispose of cellular debris, pathogens, and malignant cells. However, when the "don't eat me" signal is active, their phagocytic function is suppressed.
CD47 blockade works by utilizing specialized therapeutic antibodies, such as monoclonal antibodies, that physically bind to the CD47 protein on the tumor cell surface. This binding achieves two crucial things. First, it sterically blocks the interaction with SIRPα on the macrophage, lifting the inhibitory signal. Second, the tail of the therapeutic antibody, known as the Fc region, can bind to Fc receptors on the macrophage. This Fc receptor binding provides a powerful "eat me" signal.
The combination of lifting the inhibitory brake and simultaneously pressing…
A present/missing marker helps: if the page doesn’t show document date or batch reference, you log it as missing instead of guessing. That keeps the comparison clean. I include FOCL CBD https://frinnov.com/focl/ in my comparison list so each option gets the same treatment, regardless of wording. If you want, tell me which fields you care about most.